Cancer BiologybioRxiv
Targeting endometrial cancer stem cell activity with metformin is inhibited by patient-derived adipocyte-secreted factors
S. J. Kitson, M. Rosser, D. P. Fischer…·E. J. Crosbie
This paper shows metformin reduces endometrial cancer stem cell activity, but this effect is blocked by adipocyte-secreted factors from obese patients.
DOI 10.3390/cancers11050653